section name header

Y-Site Injection Compatibility (1:1 Mixture)

Colistimethate sodium

(Mfr: PAD)(Conc: 4.5 mg/mLa)

I

Telavancin HCl

(Mfr: ASP)(Conc: 7.5 mg/mLa)

Remarks:

Visible turbidity formed

Ref:

2830